234 related articles for article (PubMed ID: 3002918)
1. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
[TBL] [Abstract][Full Text] [Related]
2. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
[TBL] [Abstract][Full Text] [Related]
3. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of SP1 and beta-hCG in serum and cerebrospinal fluid and concentrations of hCG in urine in patients with trophoblastic tumour.
Soma H; Kikuchi K; Takayama M; Saegusa H; Saito T; Kashiwagi H; Sayama S
Arch Gynecol; 1981; 230(4):321-7. PubMed ID: 6269502
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
7. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
Sakuragi N
Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
[No Abstract] [Full Text] [Related]
8. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
Radikov N
Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
[TBL] [Abstract][Full Text] [Related]
9. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
[TBL] [Abstract][Full Text] [Related]
10. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
Lee JN; Salem HT; Chard T; Huang SC; Ouyang PC
Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
[TBL] [Abstract][Full Text] [Related]
11. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy-specific proteins as markers for gestational trophoblastic disease.
Horne CH; Rankin R; Bremner RD
Int J Gynecol Pathol; 1984; 3(1):27-40. PubMed ID: 6203853
[No Abstract] [Full Text] [Related]
13. Prognostic significance of the new placental proteins in trophoblastic disease.
Tsakok FH; Koh S; Chua SE; Ratnam SS; Teisner B; Jones GR; Sinosich M; Grudzinskas JG
Br J Obstet Gynaecol; 1983 May; 90(5):483-6. PubMed ID: 6189512
[TBL] [Abstract][Full Text] [Related]
14. Trophoblastic disease.
Ngan HY; Kohorn EI; Cole LA; Kurman RJ; Kim SJ; Lurain JR; Seckl MJ; Sasaki S; Soper JT
Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 2():S130-6. PubMed ID: 22999504
[No Abstract] [Full Text] [Related]
15. Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases.
Than GN; Bohn H; Csaba IF; Szabó DG; Karg NJ; Göcze P
Arch Gynecol; 1981; 231(1):33-9. PubMed ID: 6174083
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
Lösch A; Kainz C
Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
[TBL] [Abstract][Full Text] [Related]
17. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
18. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
[TBL] [Abstract][Full Text] [Related]
20. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]